The effect of phorbol myristate acetate (PMA) on the antibody-dependent cellular cytotoxicity (ADCC) of human polymorphonuclear leukocytes (PMNs) against human erythroleukemic K562 cells was studied by the use of a 3-h 51Cr-release assay. Pretreatment of PMNs with PMA (10 ng/ml) for 60 min resulted in inhibition of subsequent ADCC. This inhibition was dependent on doses of PMA. The effect of pretreatment of PMNs with PMA on 02 generation of the cells was also studied. The ability of the cells to generate 02 was not suppressed, and the expression of Fc receptors on the cell membrane was well preserved. In contrast, the addition of PMA to the ongoing ADCC (5 to 30 min after the start of the ADCC assay) enhanced the activity of the cells for ADCC. This augmentation was abolished by catalase, whereas ADCC itself was not affected by the agent. These results imply divalent effects of PMA on the ADCC of PMNs. The suppression of ADCC activity of PMNs by pretreatment with PMA is not due to inhibition of the reactive oxygen burst of the cells. The augmentation of ongoing ADCC by the addition of PMA is due to secretion of hydrogen peroxide from the cells induced by PMA, and this augmentation occurs only when the interaction between effector and target cells exists through Fc receptor.
The functions of phagocytic cells have been well investigated with respect to various host defense mechanisms against tumor cells and microorganisms (1) (2) (3) . Reactive oxygen species (ROS) such as hydrogen peroxide (H202) have an important role in the lysis of tumor cells by these cells (19, 21) . As superoxide anion (02) is a precursor of all ROS, the regulatory mechanisms of 02 generation for analysis of host defense mechanisms, including killing activity of the phagocytic cells against tumor cells, have to be determined.
Antibody-dependent cellular cytotoxicity (ADCC) of phagocytic cells is an important function of cells related to tumor surveillance (9, 11) . Clark and JKlebanoff (5) and Hafeman and Lucas (10) reported that ROS is responsible for the ADCC of polymorphonuclear leukocytes (PMNs) against mammalian tumor cells. However, other workers have suggested that mechanisms other than ROS generation from the phagocytic cells may be responsible for ADCC activity (4, 8, 14, 16, 17) .
Phorbol myristate acetate (PMA) is a well-known, membrane-active stimulator for ROS generation (6) and enhances the ability of the phagocytic cells to kill tumor cells (19, 21) . In addition, ADCC activity of PMNs against erythrocytes and tumor cells is augmented by this agent (15) .
In the present study, we used PMA to determine whether modulation of ROS generation from PMNs affects the ADCC activity of the cells. The data obtained showed that pretreatment of PMNs with PMA suppressed ADCC activity of the cells against tumor cells, despite the finding that 02 generation from the cells was not affected. In contrast, the addition of PMA after the start of the ADCC assay significantly enhanced the activity related to killing of the tumor cells.
MATERIALS AND METHODS
Preparation of PMNs. Heparinized peripheral blood was obtained from healthy donors. PMNs were prepared by the one-step density gradient centrifugation method, using Mono-Poly Resolving Medium (purchased from Flow Laboratories, Inc., Rockville, Md.) as described by Ferrante and Thong (7) . The PMN-rich layer formed by centrifugation at 300 x g for 30 min was harvested, and the cells were centrifuged at 250 x g for 10 min, followed by three washings in phosphate-buffered saline. PMNs Preparation of insoluble immune complexes. The purification of guinea pig anti-egg albumin immunoglobulin G2 (IgG2) antibodies was performed as described previously (24) . Insoluble immune complexes used for°2 generation and inhibition of ADCC were prepared by mixing anti-egg albumin IgG2 antibodies with egg albumin at a molar ratio of 1:1.
Determination of the amount of released 2-from PMNs treated with PMA. The 2-determination was performed as described previously (13) . Briefly, 1 ml of reaction mixture in HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer containing 100 ,uM ferricytochrome C and 5 x 106 PMNs treated with PMA for 60 min was preincubated in a plastic cuvette for a spectrophotometer at 37°C for 10 min. Insoluble immune complexes (25 ,ug of antibody per ml) and cytochalasin E (5 ,ug/ml) were then added to the reaction mixture, and the rate of SOD-inhibitable reduction of ferricytochrome C was measured continuously by recording the absorption increase at 550 to 540 nm (molar absorption coefficient, 19 x 103) with a Hitachi 556 two-beam spectrophotometer. To prevent the sedimentation of the cells, a cell mixer was attached to the cuvette as described by Kakinuma et al. (12 (18) . RESULTS Characterization of ADCC. The time course of ADCC at an effector-to-target cell ratio of 50:1 is shown in Fig. 1 . Maximum lysis of the sensitized target cells was reached at 3 h of incubation with effector cells, and there was no increase of the lysis thereafter. Cytotoxic activity of PMNs against nonsensitized target cells was always less than 5%. Dependence of Fc receptors on the cell membrane of PMNs for lysis of the sensitized target cells was deduced from the finding that ADCC activity of the cells was almost completely inhibited by blocking of Fc receptors with addition of the immune complexes (100 ,ug of antibody per ml) to the assay medium (data not shown). Inhibition of ADCC by pretreatment of PMNs with PMA. Figure 2 shows the dose-dependent inhibition of subsequent ADCC of PMNs by pretreatment of the cells with PMA for 60 min. ADCC of the cells pretreated with 0.1 ng of PMA per ml was suppressed almost 25% compared with that of control cells, and it was completely inhibited when the cells were pretreated with 10 ng of PMA per ml. Time-dependent inhibition of subsequent ADCC of PMNs by pretreatment of the cells with 10 ng of PMA per ml is shown in Fig. 3 (Fig. 4) . However, the enhancement of ADCC activity was no longer observed when PMA was added 120 min after the start of the assay. This enhancing effect of PMA was dose dependent. Maximum enhancement of ADCC was observed when 10 ng of PMA per ml was added to the well. The addition of PMA to the wells containing PMNs and nonsensitized target cells was not effective for lysis of target cells.
Abolishment of the enhancing effect of PMA by catalase. We next investigated whether SOD or catalase would be capable of abolishing the enhancing effect of PMA on ongoing ADCC. Catalase completely abolished the enhancing effect of PMA on ongoing ADCC, whereas SOD had no effect, though neither SOD nor catalase had any effect on ADCC itself (Fig. 5) . (8, 14) have found that ROS is not necessarily related to the expression of ADCC activity by the cells. The discrepancy may relate to differences in the target cells used for the ADCC assay.
To determine whether the suppressed ADCC activity of the PMA-treated cells might be due to the desensitization of the cells for the ROS system, we assayed 02 generation of the cells induced by immune complexes. We found that the PMA treatment of the cells had no significant effect on 02-generation of the cells. These results strongly suggested that mechanisms other than the ROS system were responsible for the suppressed ADCC activity by PMA, and that in our experimental system, 02 generation was not responsible for the expression of ADCC activity by those cells.
The independence of the ROS system was further con- firmed by the observation that the addition of catalase and SOD to the ADCC assay had no inhibitory effect on the ADCC activity of PMNs. At present, we know of no precise evidence to explain the mechanism for suppression of ADCC by PMA; however, it may be that the functional desensitization of PMNs is caused by pretreatment of the cells with PMA, as is the case in various other cells (22, 23) .
Contrary to the suppressive effect of PMA on subsequent ADCC, the addition of PMA to the ongoing ADCC assay (5 to 30 min after the start of the ADCC assay) enhanced the ability of the cells for ADCC. This enhancement was abolished by the addition of catalase. This finding implies that H202 produced from PMNs by stimulation with PMA is responsible for this enhancement. Furthermore, from the observation that the addition of PMA had no effect on the killing activity of PMNs against nonsensitized target cells, the direct interaction between effector and target cells through Fc receptors seems to be essential for the enhancement induced by PMA. We conclude that in our experiment, the ROS system is not involved in the expression of ADCC activity by PMNs, but has adjective effect for enhancement of the ADCC activity by the cells.
